Liver Research

North Shore Gastroenterology is actively involved in advancing liver health through ongoing liver research, clinical trials, and partnerships with regional research organizations. Our team collaborates with the Clinical Research Institute of Ohio (CRIOH) to evaluate new therapies for metabolic liver disease, fatty liver disease, cirrhosis, and alcohol-associated liver conditions. Through these liver clinical trials in Northeast Ohio, eligible patients may gain early access to investigational treatments while contributing to scientific progress. All studies follow strict safety standards and are overseen by experienced hepatology specialists.

A medical professional in blue gloves holds a cross-section anatomical model of a human liver and gallbladder

What Is a Clinical Trial?

Clinical trials are structured research studies where volunteers help evaluate new treatments, diagnostic tools, or medical approaches. These studies may offer access to therapies not yet available to the public and can sometimes include reimbursement for participation. While clinical trials are conducted with extensive oversight, investigational treatments may carry risks or side effects that are still being studied. Participants are closely monitored throughout the process to ensure safety and proper follow-up care.

Current Liver Clinical Trials

North Shore Gastroenterology, in partnership with the Clinical Research Institute of Ohio (CRIOH), offers clinical trials for the following liver conditions:

Research Contacts

For questions about current or upcoming liver studies, contact our research team:

Nina Pollard, DrPH, MPH, Clinical Research Lead

Iryna Kalinina, Certified Nurse Practitioner, Sub-Investigator

Phone: (440) 363-4000

Learn more about CRIOH by visiting the CRIOH website.

Liver Research in Northeast Ohio

To learn more about active liver studies or determine eligibility for clinical trials, contact North Shore Gastroenterology at (440) 363-4000 or request an appointment to speak with our research team and explore available opportunities in liver disease research.